CME Group, Inc.

  • Market Cap: Large Cap
  • Industry: Capital Markets
  • ISIN: US12572Q1058
USD
273.19
-4.3 (-1.55%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About CME Group, Inc. stock-summary
stock-summary
CME Group, Inc.
Capital Markets
CME Group Inc., through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company's segment primarily consists of the Chicago Mercantile Exchange Inc. (CME), Board of Trade of the City of Chicago, Inc. (CBOT), New York Mercantile Exchange, Inc. (NYMEX) and Commodity Exchange, Inc. (COMEX) exchanges. The Company provides electronic trading around the globe on its CME Globex platform. The Company also offers clearing and settlement services across asset classes for exchange-traded and over-the-counter derivatives through its clearinghouses CME Clearing and CME Clearing Europe. It also provides hosting, connectivity and customer support for electronic trading through its co-location services. The Company's CME Direct platform offers side-by-side trading of exchange-listed and privately negotiated markets.
Company Coordinates stock-summary
Company Details
20 S Wacker Dr , CHICAGO IL : 60606-7431
stock-summary
Tel: 1 312 9301000
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 210 Schemes (32.99%)

Foreign Institutions

Held by 528 Foreign Institutions (27.29%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Hon. Terrence Duffy
Executive Chairman of the Board, Chief Executive Officer
Mr. Charles Carey
Vice Chairman of the Board
Mr. Daniel Glickman
Lead Independent Director
Mr. Michael Spencer
Director
Mr. Timothy Bitsberger
Independent Director
Mr. Dennis Chookaszian
Independent Director
Ms. Elizabeth Cook
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1,692 Million
(Quarterly Results - Jun 2025)
Net Profit:
1,018 Million
stock-summary
Industry

Capital Markets

stock-summary
Market cap

USD 94,629 Million (Large Cap)

stock-summary
P/E

27.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

309.36%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

13.59%

stock-summary
Price to Book

3.41